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beparticularly useful in isolating the effects
of paracrine and autocrine signals and in
more precisely controlling the dosing and
timing of pathogen inputs.
This work demonstrates the power of
high-content single-cell techniques like
RNA-seq in understanding pathogen-
host interactions, but there is much left to
do, both on the technical and biology
sides. The researchers collected a very
rich dataset on macrophage transcription
andhighlight thePhoPQ-IFN link,but there
could be more to discover in this treasure
chest of functional single-cell data.1210 Cell 162, September 10, 2015 ª2015 ElREFERENCES
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Eickhoff et al. and Hor et al. use time-lapse intravital microscopy to show an unexpected choreog-
raphy of CD4+ and CD8+ T cells ‘‘dancing’’ between different dendritic cell sub-populations during
priming of cytotoxic immune responses to viruses.The idea that clonal selection is at the
basis of adaptive immune responses was
first proposed in the Fifties by Nils Jerne
and Sir Macfarlane Burnet. It was not,
however, until the end of the Nineties
that the field accepted that dendritic cells
(DCs), first identified in 1973 by Ralph
Steinman, are theantigen-presenting cells
that support clonal selection and initiate
adaptive immune responses in lymph
nodes. The first visual in situ dynamic
evidence of early interactions between
naive T lymphocytes and DCs came in
theearly 2000swhen two-photon intravital
imaging methods were developed in
immunology (reviewed in Pittet and Mem-
pel, 2008). These early studies revealed
a high degree of unexpected complexity
in these interactions. First, clonal selection
occurs within a complex tissue environ-
ment and within specific regions of
lymphoid tissue. Second, the encounter
of an antigen-presenting cell and a T cell
specific for that particular antigen is a
rare, non-random event. Dendritic cellsaccumulate in certain regions of lymph
nodes and T cells migrate along pre-
ferential tracks, guided by combinations
of chemokines. Third, the interactions
between T cells and DCs have a specific
controlled duration, which is critical for
clonal expansion and T cell differentiation
into effector and memory cells.
A key critical level in the initiation of im-
mune responses, however, had not yet
been addressed: DCs are a heteroge-
neous cell population that includes
multiple cell subtypes with different func-
tions. DCs fall into two main lineages
(sometimes referred to as CD103+
and CD11b+ lineages), each including
lymphoid tissue resident and migratory
cells (Merad et al., 2013). One of the line-
ages (CD103+, CD8aa+, and XCR1+)
specializes in the induction of CD8+
T cell responses and the presentation
of internalized antigens on class I MHC
molecules (cross-presentation) and will
be referred to as XCR1+ DCs. The other
subtype is more heterogeneous. CD11b+DCs present internalized antigens on
preferentially class II MHC molecules
and induce CD4+ T cell and B cell re-
sponses (Merad et al., 2013). The current
view of DC biology therefore underlines
a repartition of antigen presentation to
CD4+ and CD8+ T cells between DC
subpopulations.
On the other hand, effective anti-viral
cytotoxic immune responses by CD8+
T cells are strictly dependent on CD4+
T cells. In the absence of CD4+ T cells,
CD8+ T cell responses are weak and
lack long-lasting memory protection
(Janssen et al., 2003; Shedlock and
Shen, 2003). Different models have been
proposed to account for these observa-
tions. The first proposed that CD4+
T cell help requires direct interactions
between the three cell types (CD4+,
CD8+ T cells, and DCs) (Ridge et al.,
1998). The likelihood of this three-way
cell interaction was questionable, and
subsequent studies showed that the three
cell types do not need to interact
Figure 1. XCR1+ DC Platforms for T Cell Help during the Initiation of Anti-viral Immune
Responses
Both CD4+ and CD8+ T cells are initially activated by distinct DCs in different anatomical sites of lymphoid
organs. Activated T cells migrate to T cell zones and interact simultaneously in clusters containing the
three-cell type. These three-cell interactions are indispensable for effector and memory anti-viral CD8+
T cell responses.simultaneously. CD4+ cells deliver to DCs
a ‘‘licensing’’ signal (through CD40-
CD40L interactions) that activates DCs
and permits the effective induction of
CD8+ T cell responses (Schoenberger
et al., 1998). This last model of T cell
help does not predict simultaneous inter-
actions between the three cell types.
Two studies now published in Cell
(Eickhoff et al., 2015) and Immunity
(Hor et al., 2015) investigate the nature
of the cell-cell interactions that occur
during the initiation of cytotoxcic CD8+
T cell responses using intravital imaging
in different viral infection models. Eickhoff
et al. (2015) show that, early after
infection by ovalbumin or LCMV glyco-
protein expressing Vaccinia virus (MVA),
CD8+ T cells are found within a series
of dynamic clusters around infected
DCs. These clusters, as well as initial
priming of antigen-specific CD8+ T cells,
do not require macrophages or resident
XCR1+ DCs but another population of
unidentified, MVA-OVA-infected DCs.
When OVA-specific CD4+ T cells are
also present, they form separate clusters,
which do not contain CD8+ T cells and
are found in the white pulp, whereas
the CD8+ clusters are present in the mar-
ginal zone. CD8+ and CD4+ T cell initial
priming therefore occurs in different
anatomical localizations and on different
individual DCs.
The study by Hor et al. (2015) makes
a similar initial observation using a
model of cutaneous HSV-1 infection in
which HSV-1-specific CD4+ T cells
expand earlier than CD8+ T cells. Theyalso show that early CD4+ T cell clus-
ters in skin-draining lymph nodes are
found in the medullary, the subcapsular
sinus, and the B cell follicles rather
than in the T cell zones. Using dynamic
intravital imaging, they show that the
early CD4+ cell clusters do not contain
HSV-1-specific CD8+ T cells. Early
CD8+ T cell clusters form around migra-
tory skin DCs and not lymph node resi-
dent DCs. Therefore, like in the case of
Vaccinia virus, after infection by HSV-1,
the early priming of CD4+ and CD8+
T cells is physically segregated and
seems to occur on distinct DC popula-
tions.
How then is CD4+ T cell help delivered
to CD8+ T cells? The licensing model
would have predicted that the DCs that
had interacted with CD4+ T cells (the
migratory ones in the case of HSV-1 and
a CD11b+ population in the case of
MVA) would then interact with CD8+
T cells to deliver the T cell help. This is
not what was observed. In contrast,
both studies show that, after infection
(40 hr in both the HSV-1 and the
MVA models), dynamic clusters contain
both CD4+ and CD8+ antigen-specific
T cells. Eickhoff et al. (2015) show that
these late ‘‘mix’’ clusters are present in
the peripheral paracortex of the spleen.
Hor et al. (2015) show that these clusters
exclude migratory tissue-derived DCs
and that the mix clusters form around
XCR1+ DCs, suggesting that XCR1+
DCs present antigen on both class I and
II MHC molecules. In the HSV-1 model,
the same group showed previously thatCell 162, Septhe activation of CD8+ T cells is not
induced by infected migratory DCs, but
rather by cross-presentation after antigen
transfer to resident DCs (Allan et al.,
2006). Eickhoff et al. (2015) go one-step
further using XCR1-DTR mice, in which
DTX injection results in the specific
depletion of XCR1+ resident DCs. Deple-
tion of XCR1+ DCs caused loss of the mix
CD4+/CD8+ T cell clusters, but not of
single CD4+ or CD8+ T cell clusters,
suggesting again that initial activation of
both CD4+ and CD8+ T cells occurs on
XCR1-negative DCs (migratory DCs for
CD4+ T cells, in the case of HSV-1, and
probably other populations of resident
DCs in the case of MVA). The results
from both studies indicate that XCR1+
DCs represent a ‘‘platform’’ for dynamic
interactions between CD4+ and CD8+
T cells.
The final set of experiments in Eickhoff
et al. (2015) addresses the physiological
relevance of XCR1+ DCs for T cell help
to cytotoxic effector and memory re-
sponses. They show that depletion of
XCR1+ DCs deprives CD8+ T cells from
CD4+ T cell help. These ‘‘helpless’’
CD8+ T cells display reduced expansion
and differentiation after Vacinia virus
infection, and memory cytotoxic re-
sponses are compromised. Importantly,
Eickhoff et al. (2015) show that selective
KO of class II MHC molecules on XCR1+
DCs is sufficient to reproduce the pheno-
type, suggesting that antigen presenta-
tion to CD4+ T cells is required.
These studies make a critical contribu-
tion to our understanding of the initiation
of cytotoxic immune responses to virus.
They show that the initial priming of
CD8+ T and CD4+ T cells occurs on
different DC populations and that a sec-
ondary three-cell relationship is orches-
trated by XCR1+ DCs (Figure 1). These
XCR1+ DCs are not directly infected
and must present viral antigens on both
class I and II MHC molecules. They are
absolutely required for effective cytotoxic
primary and memory T cell responses.
Previous studies showed that XCR1+
DCs are the most efficient antigen
cross-presenting DCs (Merad et al.,
2013). Their role as ‘‘platforms’’ for deliv-
ering CD4+ T cell help suggests that
cross-presentation is not their only crit-
ical contribution to the initiation of cyto-
toxic immune responses. The productiontember 10, 2015 ª2015 Elsevier Inc. 1211
of IL12, which is far higher in XCR1+ DCs
than in other DC types, may also be
important. It is also likely that XCR1+
DCs express a unique set of chemokines
and chemokine receptors, maybe
including XCR1 itself, that determines
their function. It will be important to
investigate how this new model for
T cell help applies to other CD8+ T cell
responses, including anti-tumor re-
sponses.
A key step for future research will
certainly be to unravel the role of DC
subpopulations during the initiation of
immune responses in humans. Both
T cell and DC lineage organizations are
conserved between human and mice.
However, in both cases, the functions of
the subsets seem to have evolved differ-
ently. CD4+ human T cells are often cyto-
toxic, and it is still unclear if the human1212 Cell 162, September 10, 2015 ª2015 Ellineage homologs of XCR1+ DCs, which
express BDCA3+ and CD141+, cross-
present antigens more efficiently than
other DC subsets. In addition, the produc-
tion of IL-12 is clearly not restricted to the
human CD141+ DCs. Determining which
human DC, if any, functions as a ‘‘T cell
help platform’’ will certainly be a major
challenge in the next years and an essen-
tial step toward designing effective CD8+
T cell vaccines.
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In this issue, Farez et al. report that the circadian hormone melatonin, whose levels vary with sea-
sonal changes in night length, shifts the immune response toward an anti-inflammatory state that
may explain the seasonal variability of multiple sclerosis disease activity.An imbalance between the inflammatory
and regulatory responses of the immune
system can lead to chronic immune cell
activation and autoimmunity. Mounting
evidence implicates the Th17 subset of
T helper cells, characterized by the pro-
duction of the proinflammatory cytokine
interleukin-17 (IL-17), with playing a cen-
tral role in autoimmune diseases,
including multiple sclerosis (MS), rheu-
matoid arthritis (RA), psoriasis, and in-
flammatory bowel disease (IBD) (Gaffen
et al., 2014). Predominantly located at
barrier tissues that interface with the
external world, Th17 cells maintain a
high degree of flexibility to respond
rapidly to constant fluctuations in envi-
ronmental conditions and stimuli. Themechanisms that allow the adaptation
of Th17 cells to the ever-changing envi-
ronment include the ability to respond to
changing nutrient status through the aryl
hydrocarbon receptor (AHR) (Quintana
et al., 2008), to oxygen sensing path-
ways including HIF1a (Dang et al.,
2011), and to changes in osmotic pres-
sure through serum/glucocorticoid regu-
lated kinase 1 (SGK1) (Wu et al., 2013).
In this issue of Cell, Farez et al. (2015)
uncover another environmental cue—
seasonal changes in daylight—that
modulates the development of patho-
genic Th17 cells. The daylight effect is
mediated by the hormone melatonin,
produced by the pineal gland and
involved in the regulation of the circa-dian rhythm (Brzezinski, 1997). Mela-
tonin inhibits the development of proin-
flammatory Th17 cells and shifts the
balance of the immune response toward
immunosuppression.
It has been known for some time that
the latitudinal gradient—the greater the
distance from the equator— correlates
with increasing occurrence of multiple
sclerosis (Alonso and Herna´n, 2008).
One of the phenomena linked to latitude
is seasonal variation in exposure to UV
radiation. There are convincing epidemi-
ological data supporting the role of UV
radiation-dependent vitamin D in
reducing the disease course of MS
(Munger et al., 2004). Yet, this correlation
does not explain the increase in MS
